Johnson & Johnson News - October 2026
Smith & Nephew Merger Talks With J&J Collapse Over Leadership
Advanced merger talks between Smith & Nephew and Johnson & Johnson’s orthopaedics unit, DePuy Synthes, have collapsed. The reported sticking point was a...
🟢 Johnson & Johnson is trading 3.13% up today after favorable atrial-fibrillation treatment data
Johnson & Johnson is trading at $265.84, up +3.13%, with favorable atrial-fibrillation data cited as a positive contributor to shares’ sentiment. - In its...
Johnson & Johnson’s third quarter 2026 sales matched estimates at $25.4B while Innovative Medicine outperformed
Johnson & Johnson reported third quarter 2026 results featuring solid operational sales growth of 6.0%, driven by outperformance in its Innovative Medicine...
Johnson & Johnson Q3 2026 Earnings Preview: What Analysts Expect on October 13, 2026
Consensus estimates for Johnson & Johnson's third quarter of 2026 call for revenue of $25.40 billion and adjusted EPS of $2.66, as the stock trades near...